- •INTERNAL MEDICINE
- •Medical Documentation
- •History and Physical Examination
- •Admission Check List
- •Progress Notes
- •Procedure Note
- •Discharge Note
- •Discharge Summary
- •Prescription Writing
- •Cardiovascular Disorders
- •Congestive Heart Failure
- •Supraventricular Tachycardia
- •Ventricular Arrhythmias
- •Hypertensive Emergencies
- •Hypertension
- •Syncope
- •Pulmonary Disorders
- •Asthma
- •Chronic Obstructive Pulmonary Disease
- •Hemoptysis
- •Anaphylaxis
- •Pleural Effusion
- •Hematologic Disorders
- •Anticoagulant Overdose
- •Deep Venous Thrombosis
- •Pulmonary Embolism
- •Sickle Cell Crisis
- •Meningitis
- •Infectious Diseases
- •Infective Endocarditis
- •Pneumonia
- •Specific Therapy for Pneumonia
- •Diverticulitis
- •Lower Urinary Tract Infection
- •Pyelonephritis
- •Osteomyelitis
- •Active Pulmonary Tuberculosis
- •Cellulitis
- •Pelvic Inflammatory Disease
- •Gastrointestinal Disorders
- •Gastroesophageal Reflux Disease
- •Peptic Ulcer Disease
- •Gastrointestinal Bleeding
- •Cirrhotic Ascites and Edema
- •Viral Hepatitis
- •Cholecystitis and Cholangitis
- •Acute Pancreatitis
- •Acute Gastroenteritis
- •Ulcerative Colitis
- •Enteral Nutrition
- •Hepatic Encephalopathy
- •Alcohol Withdrawal
- •Toxicology
- •Poisoning and Drug Overdose
- •Acetaminophen Overdose
- •Theophylline Overdose
- •Tricyclic Antidepressant Overdose
- •Neurologic Disorders
- •Ischemic Stroke
- •Transient Ischemic Attack
- •Subarachnoid Hemorrhage
- •Seizure and Status Epilepticus
- •Endocrinologic Disorders
- •Nephrologic Disorders
- •Diabetic Ketoacidosis
- •Nonketotic Hyperosmolar Syndrome
- •Renal Failure
- •Nephrolithiasis
- •Hypercalcemia
- •Hypocalcemia
- •Hyperkalemia
- •Hypokalemia
- •Hypermagnesemia
- •Hypomagnesemia
- •Hypernatremia
- •Hyponatremia
- •Hyperphosphatemia
- •Hypophosphatemia
- •Rheumatologic Disorders
- •Systemic Lupus Erythematosus
- •Acute Gout Attack
- •PEDIATRICS
- •General Pediatrics
- •Pediatric History and Physical Examination
- •Progress Notes
- •Discharge Note
- •Prescription Writing
- •Developmental Milestones
- •Immunizations
- •Haemophilus Immunization
- •Varicella Immunization
- •Influenza Immunization
- •Pediatric Symptomatic Care
- •Antipyretics
- •Analgesia and Sedation
- •Antiemetics
- •Cardiovascular Disorders
- •Pediatric Advanced Life Support
- •Congestive Heart Failure
- •Pulmonary Disorders
- •Asthma
- •Infectious Diseases
- •Suspected Sepsis
- •Meningitis
- •Pneumonia
- •Specific Therapy for Pneumonia
- •Bronchiolitis
- •Varicella Zoster Infections
- •Lower Urinary Tract Infection
- •Otitis Media
- •Epiglottitis
- •Sinusitis
- •Active Pulmonary Tuberculosis
- •Cellulitis
- •Tetanus
- •Pelvic Inflammatory Disease
- •Pediculosis
- •Scabies
- •Dermatophytoses
- •Gastrointestinal Disorders
- •Gastroenteritis
- •Specific Therapy for Gastroenteritis
- •Hepatitis A
- •Hepatitis B
- •Parenteral Nutrition
- •Gastroesophageal Reflux
- •Constipation
- •Toxicology
- •Poisonings
- •Antidotes to Common Poisonings
- •Acetaminophen Overdose
- •Iron Overdose
- •Seizure and Status Epilepticus
- •New-Onset Diabetes
- •Diabetic Ketoacidosis
- •Sickle Cell Crisis
- •Kawasaki Disease
- •Fluids and Electrolytes
- •Dehydration
- •Hyperkalemia
- •Hypokalemia
- •Hypernatremia
- •Hyponatremia
- •Hypophosphatemia
- •Hypomagnesemia
- •Newborn Care
- •Neonatal Resuscitation
- •Suspected Neonatal Sepsis
- •Respiratory Distress Syndrome
- •Chronic Lung Disease
- •Hyperbilirubinemia
- •GYNECOLOGY
- •Gynecologic Surgical History
- •Surgical Progress Note
- •Procedure Note
- •Discharge Note
- •Postoperative Check
- •General Gynecology
- •Cervical Intraepithelial Neoplasia
- •Colposcopy
- •Contraception
- •Acute Pelvic Pain
- •Chronic Pelvic Pain
- •Primary Amenorrhea
- •Secondary Amenorrhea
- •Menopause
- •Abnormal Vaginal Bleeding
- •Breast Cancer Screening and Diagnosis
- •Evaluation of Breast Lumps
- •Benign Breast Disease
- •Sexual Assault
- •Osteoporosis
- •Urinary Incontinence
- •Urinary Tract Infection
- •Pubic Infections
- •Sexually Transmissible Infections
- •Pelvic Inflammatory Disease
- •Vaginitis
- •Obstetrics
- •Prenatal Care
- •Normal Labor
- •Labor History and Physical
- •Labor and Delivery Admitting Orders
- •Active Management of Labor
- •Perineal Lacerations and Episiotomies
- •Fetal Heart Rate Assessment
- •Antepartum Fetal Surveillance
- •Cesarean Section Operative Report
- •Postoperative Management after Cesarean Section
- •Prevention of D Isoimmunization
- •Complications of Pregnancy
- •Spontaneous Abortion
- •Urinary Tract Infections in Pregnancy
- •Gestational Diabetes Mellitus
- •Group B Streptococcal Infection in Pregnancy
- •Premature Rupture of Membranes
- •Preterm Labor
- •Bleeding in the Second Half of Pregnancy
- •Preeclampsia
- •Dystocia and Augmentation of Labor
- •Shoulder Dystocia
- •Induction of Labor
- •Postpartum Hemorrhage
- •Acute Endometritis
- •Postpartum Fever Workup
- •Commonly Used Formulas
both uterine atony and rupture.
E.Uterine inversion is detected by abdominal vaginal examination, which will reveal a uterus with an unusual shape after delivery.
II. Management of postpartum hemorrhage
A.Following delivery of the placenta, the uterus should be palpated to determine whether atony is present. If atony is present, vigorous fundal massage should be administered. If bleeding continues despite uterine massage, it can often be controlled with bimanual uterine compression.
B.Genital tract lacerations should be suspected in patients who have a firm uterus, but who continue to bleed. The cervix and vagina should be inspected to rule out lacerations. If no laceration is found but bleeding is still profuse, the uterus should be manually examined to exclude rupture.
C.The placenta and uterus should be examined for retained placental fragments. Placenta accreta is usually manifest by failure of spontaneous placental separation.
D.Bleeding from non-genital areas (venous puncture sites) suggests coagulopathy. Laboratory tests that confirm coagulopathy include INR, partial thromboplastin time, platelet count, fibrinogen, fibrin split products, and a clot retraction test.
E.Medical management of postpartum hemorrhage
1.Oxytocin (Pitocin) is usually given routinely immediately after delivery to stimulate uterine firmness and diminish blood loss. 20 units of oxytocin in 1,000 mL of normal saline or Ringer's lactate is administered at 100 drops/minute. Oxytocin should not be given as a rapid bolus injection because of the potential for circulatory collapse.
2.Methylergonovine (Methergine) 0.2 mg can be given IM if uterine massage and oxytocin are not effective in correcting uterine atony and provided there is no hypertension.
3.15-methyl prostaglandin F2-alpha (Hemabate), one ampule (0.25 mg), can be given IM, with repeat injections every 20min, up to 4 doses can be given if hypertension is present; it is contraindicated in asthma.
Treatment of Postpartum Hemorrhage Secondary to Uterine Atony
Drug |
Protocol |
|
|
Oxytocin |
20 U in 1,000 mL of lactated Ringer's |
|
as IV infusion |
|
|
Methylergonovine (Methergine) |
0.2 mg IM |
|
|
Prostaglandin (15 methyl |
0.25 mg as IM every 15-60 minutes as |
PGF2-alpha [Hemabate, |
necessary |
Prostin/15M]) |
|
F.Volume replacement
1.Patients with postpartum hemorrhage that is refractory to medical therapy require a second large-bore IV catheter. If the patient has had a major blood group determination and has a negative indirect Coombs test, type-specific blood may be given without waiting for a complete cross-match. Lactated Ringer's solution or normal saline is generously infused until blood can be replaced. Replacement consists of 3 mL of crystalloid solution per 1 mL of blood lost.
2.A Foley catheter is placed, and urine output is maintained at greater than 30 mL/h.
G.Surgical management of postpartum hemorrhage. If medical therapy fails, ligation of the uterine or uteroovarian artery, infundibulopelvic vessels, or hypogastric arteries, or hysterectomy may be indicated.
H.Management of uterine inversion
1.The inverted uterus should be immediately repositioned vaginally. Blood and/or fluids should be administered. If the placenta is still attached, it should not be removed until the uterus has been repositioned.
2.Uterine relaxation can be achieved with a halogenated anesthetic agent. Terbutaline is also useful for relaxing the uterus.
3.Following successful uterine repositioning and placental
separation, oxytocin (Pitocin) is given to contract the uterus.
References: See page 155.
Acute Endometritis
Acute endometritis is characterized by the presence of microabscesses or neutrophils within the endometrial glands.
I.Classification of endometritis
A.Acute endometritis in the nonobstetric population is usually related to pelvic inflammatory disease (PID) secondary to sexually transmitted infections or gynecologic procedures. Acute endometritis in the obstetric population occurs as a postpartum infection, usually after a labor concluded by cesarean delivery.
B.Chronic endometritis in the nonobstetric population is due to infections (eg, chlamydia, tuberculosis, and other organisms related to cervicitis and PID), intrauterine foreign bodies (eg, intrauterine device, submucous leiomyoma), or radiation therapy. In the obstetric population, chronic endometritis is associated with retained products of conception after a recent pregnancy.
C.Symptoms in both acute and chronic endometritis consist of abnormal vaginal bleeding and pelvic pain. However, patients with acute endometritis frequently have fevers in contrast to
chronic endometritis.
II.Postpartum endometritis
A.Endometritis in the postpartum period refers to infection of the decidua (ie, pregnancy endometrium), frequently with extension into the myometrium (endomyometritis) and parametrial tissues (parametritis).
B.The single most important risk factor for postpartum endometritis is route of delivery. The incidence of endometritis after a vaginal birth is less than three percent, but is 5 to 10 times higher after cesarean delivery.
C.Other proposed risk factors include prolonged labor, prolonged rupture of membranes, multiple vaginal examinations, internal fetal monitoring, maternal diabetes, presence of meconium, and low socioeconomic status.
D.Microbiology. Postpartum endometritis is usually a polymicrobial infection, produced by a mixture of aerobes and anaerobes from the genital tract.
Type and Frequency of Bacterial Isolates in Postpartum
Endometritis*
Isolate |
Frequency (percent) |
|
|
Gram positive |
8 |
Group B streptococci |
|
Enterococci |
7 |
S. epidermidis |
9 |
Lactobacilli |
4 |
Diphtheroids |
2 |
S. Aureus |
1 |
|
|
Gram negative |
15 |
G. vaginalis |
|
E. Coli |
6 |
Enterobacterium spp. |
2 |
P. mirabilis |
2 |
Others |
3 |
|
|
Anaerobic |
11 |
S. bivius |
|
Other Bacteroides spp. |
9 |
Peptococci-peptostreptocci |
22 |
|
|
Mycoplasma |
39 |
U. urealyticum |
|
M. hominis |
11 |
|
|
C. trachomatis |
2 |
|
|
E.Vaginal colonization with group B streptococcus (GBS) is a risk factor for postpartum endometritis; GBS colonized women at delivery have an 80 percent greater likelihood of developing postpartum endometritis.
F.Clinical manifestations and diagnosis. Endometritis is characterize, by fever, uterine tenderness, foul lochia, and leukocytosis that develop within five days of delivery. A temperature greater than or equal to 100.4 ºF (38 ºC) in the absence of other causes of fever, such as pneumonia, wound cellulitis, and urinary tract infection is the most common sign.
G.Laboratory studies are not diagnostic since leukocytosis occurs frequently in all postpartum patients. However, a rising neutrophil count associated with elevated numbers of bands is suggestive of infectious disease. Bacteremia occurs in 10 to 20 percent of patients; usually a single organism is identified despite polymicrobial infection. Blood cultures should be obtained in febrile patients following delivery.
H.Treatment
1.Postpartum endometritis is treated with broad spectrum parenteral antibiotics including coverage for beta-lactamase producing anaerobes. The standard treatment of clindamycin (900 mg q8h) plus gentamicin (1.5 mg/kg q8h) is safe and effective, with reported cure rates of 90 to 97 percent.
Antibiotic Regimens for Endometritis
Clindamycin (900 mg IV Q 8 hours) plus gentamicin (1.5 mg/kg IV Q 8 hours)
Ampicillin-sulbactam (Unasyn) 3 grams IV Q 6 hours Ticarcillin-clavulanate (Timentin)3.1 grams IV Q 4 hours Cefoxitin (Mefoxin) 2 grams IV Q 6 hours
Ceftriaxone (Rocephin) 2 grams IV Q 24 hours plus metronidazole 500 mg PO or IV Q 8 hours*
Levofloxacin (Levaquin) 500 mg IV Q 24 hours plus metronidazole 500 mg PO or IV Q 8 hours*
* Should not be given to breastfeeding mothers
If chlamydia infection is suspected, azithromycin 1 gram PO for one dose should be added to the regimen
2.Treatment should continue until the patient is clinically improved and afebrile for 24 to 48 hours. Oral antibiotic therapy is not necessary after successful parenteral treatment, unless bacteremia is present.
3.Modifications in therapy may be necessary if there is no response to the initial antibiotic regimen after 48 to 72 hours. Approximately 20 percent of treatment failures are due to resistant organisms, such as enterococci which are not covered by cephalosporins or clindamycin plus gentamicin. The addition of ampicillin (2 g q4h) to the regimen can improve the response rate. Metronidazole (500 mg PO or IV q8h) may be more effec-
tive than clindamycin against Gram negative anaerobes but is generally not used in mothers who will be breastfeeding.
References: See page 155.
Postpartum Fever Workup
History: Postpartum fever is >100.4 F (38 degrees C) on 2 occasions >6h apart after the first postpartum day (during the first 10 days postpartum), or >101 on the first postpartum day. Dysuria, abdominal pain, distention, breast pain, calf pain.
Predisposing Factors: Cesarean section, prolonged labor, premature rupture of membranes, internal monitors, multiple vaginal exams, meconium, manual placenta extraction, anemia, poor nutrition. Physical Examination: Temperature, throat, chest, lung exams; breasts, abdomen. Costovertebral angle tenderness, uterine tenderness, phlebitis, calf tenderness; wound exam. Speculum exam. Differential Diagnosis: UTI, upper respiratory infection, atelectasis, pneumonia, wound infection, mastitis, episiotomy abscess; uterine infection, deep vein thrombosis, pyelonephritis, pelvic abscess.
Labs: CBC, SMA7, blood C&S x 2, catheter UA, C&S. Gonococcus culture, chlamydia; wound C&S, CXR.
References
References may be obtained at www.ccspublishing.com/ccs
Commonly Used Formulas
A-a gradient = [(PB-PH2O) FiO2 - PCO2/R] - PO2 arterial
= (713 x FiO2 - pCO2/0.8 ) -pO2 arterial
PB = 760 mmHg; PH2O = 47 mmHg ; R . 0.8 normal Aa gradient <10-15 mmHg (room air)
Arterial oxygen capacity = (Hgb(gm)/100 mL) x 1.36 mL O2/gm Hgb
Arterial O2 content = 1.36(Hgb)(SaO2)+0.003(PaO2)= NL 20 vol%
O2 delivery = CO x arterial O2 content = NL 640-1000 mL O2/min
Cardiac output = HR x stroke volume
CO L/min = |
125 mL O2/min/M2 |
x 100 |
|
8.5 {(1.36)(Hgb)(SaO2) - (1.36)(Hgb)(SvO2)} |
|
Normal CO = 4-6 L/min
Na (mEq) deficit = 0.6 x (wt kg) x (desired [Na] - actual [Na])
SVR = MAP - CVP x 80 = NL 800-1200 dyne/sec/cm2
COL/min
PVR = PA - PCWP x 80 = NL 45-120 dyne/sec/cm2
CO L/min
GFR mL/min = (140 - age) x wt in kg
72 (males) x serum creatinine (mg/dL)
85 (females) x serum creatinine (mg/dL)
Normal creatinine clearance = 100-125 mL/min(males), 85-105(fem- ales)
Body water deficit (L) = 0.6(weight kg)([measured serum Na]-140) 140
Serum Osmolality = 2 [Na] + BUN + Glucose = 270-290
2.818
Na (mEq) deficit = 0.6 x (wt kg)x(desired [Na] - actual [Na])
Fractional excreted Na = U Na/ Serum Na x 100 = NL<1% U creatinine/ Serum creatinine
Anion Gap = Na - (Cl + HCO3)
For each 100 mg/dL 8 in glucose, Na+ 9 by 1.6 mEq/L.
Corrected = measured Ca mg/dL + 0.8 x (4 - albumin g/dL) serum Ca+ (mg/dL)
Predicted Maximal Heart Rate = 220 - age
Normal ECG Intervals (sec)
PR |
0.12-0.20 |
QRS |
0.06-0.08 |
Heart rate/min |
Q-T |
60 |
0.33-0.43 |
70 |
0.31-0.41 |
80 |
0.29-0.38 |
90 |
0.28-0.36 |
100 |
0.27-0.35 |
Total Parenteral Nutrition Equations:
Caloric Requirements: (Harris-Benedict Equations) Basal energy expenditure (BEE)
Females: 655 + (9.6 x wt in kg) + (1.85 x ht in cm) - (4.7 x age) Males: 66 + (13.7 x wt in kg) + (5 x ht in cm) - (6.8 x age)
A.BEE x 1.2 = Caloric requirement for minimally stressed patient
B.BEE x 1.3 = Caloric requirement for moderately stressed patient (inflammatory bowel disease, cancer, surgery)
C.BEE x 1.5 = Caloric requirement for severely stressed patient (major sepsis, burns, AIDS, liver disease)
D.BEE x 1.7 = Caloric requirement for extremely stressed patient (traumatic burns >50%, open head trauma, multiple stress)
Protein Requirements:
A.0.8 gm protein/kg = Protein requirement for nonstressed patient.
B.1.0-1.5 gm protein/kg = Protein requirement for patients with decreased visceral protein states (hypoalbumiaemia), recent weight loss, or hypercatabolic states.
C.>1.5 gm protein/kg = Protein requirement for patients with negative nitrogen balance receiving 1.5 gm protein/kg
Estimation of Ideal Body Weight:
A.Females: 5 feet (allow 100 lbs) + 5 lbs for each inch over 5 feet
B.Males: 5 feet (allow 106 lbs) + 6 lbs for each inch over 5 foot
Drug Levels of Commonly Used Medications
DRUG |
THERAPEUTIC RANGE* |
Amikacin |
Peak 25-30; trough <10 mcg/mL |
Amitriptyline |
100-250 ng/mL |
Carbamazepine |
4-10 mcg/mL |
Chloramphenicol |
Peak 10-15; trough <5 mcg/mL |
Desipramine |
150-300 ng/mL |
Digitoxin |
10-30 ng/mL |
Digoxin |
0.8-2.0 ng/mL |
Disopyramide |
2-5 mcg/mL |
Doxepin |
75-200 ng/mL |
Ethosuximide |
40-100 mcg/mL |
Flecainide |
0.2-1.0 mcg/mL |
Gentamicin |
Peak 6.0-8.0; trough <2.0 mcg/mL |
Imipramine |
150-300 ng/mL |
Lidocaine |
2-5 mcg/mL |
Lithium |
0.5-1.4 mEq/L |
Nortriptyline |
50-150 ng/mL |
Phenobarbital |
10-30 mEq/mL |
Phenytoin** |
8-20 mcg/mL |
Procainamide |
4.0-8.0 mcg/mL |
Quinidine |
2.5-5.0 mcg/mL |
Salicylate |
15-25 mg/dL |
Streptomycin |
Peak 10-20; trough <5 mcg/mL |
Theophylline |
8-20 mcg/mL |
Tocainide |
4-10 mcg/mL |
Valproic acid |
50-100 mcg/mL |
Vancomycin |
Peak 30-40; trough <10 mcg/mL |
*The therapeutic range of some drugs may vary depending on the reference lab used.
**Therapeutic range of phenytoin is 4-10 mcg/mL in presence of significant azotemia and/or hypoalbuminemia.
Pediatric and Obstetric Formulas
Normal urine output = 50 ml/kg/d Oliguria = 0.5 ml/kg/h
Normal feedings = 5 oz/kg/d
Formula = 20 calories/ounce, 24 cal/oz, 27 cal/oz Ounce = 30 cc
Caloric Needs = 100 cal/kg/d
Calories/Kg = cc of formula x 30 cc/oz x 20 calories/oz divided by weight.
Weight in Kg = pounds divided by 2.2
Weight in Kg = [age in years x 2] +10
Blood volume (ml) = 80 ml/kg x weight (kg)
Blood Products:
10 cc/kg RBC will raise Hct 5%
0.1 unit/kg platelets will raise platelet count, 25000/mm3. 1 U/kg of Factor VIII will raise level by 2%.
Naegele's Rule: LMP minus 3 months plus 7 days = Estimated date of confinement.
GFR = (140 - age) x wt in Kg 85 x serum Cr
Normal Cr clearance = 85-105
Commonly Used Drug Levels
Drug |
Therapeutic Range |
|
|
Amikacin |
Peak 25-30; trough <10 mcg/mL |
Amiodarone |
1.0-3.0 mcg/mL |
Amitriptyline |
100-250 ng/mL |
Carbamazepine |
4-10 mcg/mL |
Desipramine |
150-300 ng/mL |
Digoxin |
0.8-2.0 ng/mL |
Disopyramide |
2-5 mcg/mL |
Doxepin |
75-200 ng/mL |
Flecainide |
0.2-1.0 mcg/mL |
Gentamicin |
Peak 6.0-8.0; trough <2.0 mcg/mL |
Imipramine |
150-300 ng/mL |
Lidocaine |
2-5 mcg/mL |
Lithium |
0.5-1.4 mEq/L |
Mexiletine |
1.0-2.0 mcg/mL |
Nortriptyline |
50-150 ng/mL |
Phenobarbital |
10-30 mEq/mL |
Phenytoin |
8-20 mcg/mL |
Procainamide |
4.0-8.0 mcg/mL |
Quinidine |
2.5-5.0 mcg/mL |
Salicylate |
15-25 mg/dL |
Streptomycin |
Peak 10-20; trough <5 mcg/mL |
Theophylline |
8-20 mcg/mL |
Tocainide |
4-10 mcg/mL |
Valproic acid |
50-100 mcg/mL |
Vancomycin |
Peak 30-40; trough <10 mcg/mL |